Targeted drugs that attack the genetic machinery of cancer with laser-like precision are, in a select group of patients, melting tumors away, often with few side effects. The problem is, almost invariably, these medications eventually stop working. … “It’s so much in our thinking today. As soon as we have an effective drug, we start thinking, ‘How does the drug begin to lose its benefit?” said Dr. Pasi Janne, an oncologist at Dana-Farber Cancer Institute. “This is really rising to the forefront.”
http://www.boston.com/lifestyle/health/articles/2011/11/21/successes_in_fighting_cancer_bring_new_challenge_drug_resistance/
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure